An Ever Growing Portfolio of Diverse Healthcare Companies

Provides software, services, information and connectivity solutions to enable healthcare providers to deliver best-in-class patient safety, clinical outcomes and financial results

Provides medical devices for the treatment of structural heart diseases

Produces injectable implant products used in minimally invasive soft tissue augmentation procedures

Emerging biopharmaceutical company which develops novel products to address unmet medical needs

Develops complete human genome sequencing and analysis

Develops products to address the need for surgical sealing and post-surgical adhesion prevention applications

Develops topical formulations for pharmaceutical and biotech companies

Focuses on acquiring, developing and investing in products to translate innovative science into meaningful health care consumer brands

Developed a method to safely and more effectively deliver vaccines through the use of a skin patch and without injections

Develops and markets biologic products for the repair or replacement of damaged or inadequate tissues.

Develops proprietary technology for noninvasive cosmetic surgery applications

Develops novel solutions for vascular disease

Orthopedic surgical biomaterials company offering advanced bone regeneration and soft tissue healing technologies

Assists clients in the worldwide pharmaceutical, biotechnology and medical device industries with the development and launch of their products for safe and effective treatments

Develops and commercializes branded cardiovascular injectable products

Discovers and commercializes novel antibody based drugs and drug targets for the major mental and neuro-degenerative diseases

Provides biological products and enabling technologies to life sciences companies for use in the research, development, and manufacture of new drugs and other life sciences products

Focuses on enabling people with life-altering conditions to lead better lives

Develops medical devices used during spinal fusion surgical procedures

Manufactures the X-STOP® Interspinous Process Decompression (IPD®) System, the first FDA-approved interspinous process device for treating lumbar spinal stenosis

Develops and commercializes innovative therapies for the prevention and treatment of diseases with significant unmet medical need

Acquires, develops and markets prescription pharmaceutical products to treat pain and related conditions

Focuses on the development of oral small molecule drugs for major unmet medical needs that treat male and female reproductive disorders (formerly known as Zonagen)